[go: up one dir, main page]

NO20014022L - Anvendelse av kjönnshormoner for å oppnå en nasal farmasöytisk sammensetning som er nyttig i behandlingen av uönsketlivmorblödning - Google Patents

Anvendelse av kjönnshormoner for å oppnå en nasal farmasöytisk sammensetning som er nyttig i behandlingen av uönsketlivmorblödning

Info

Publication number
NO20014022L
NO20014022L NO20014022A NO20014022A NO20014022L NO 20014022 L NO20014022 L NO 20014022L NO 20014022 A NO20014022 A NO 20014022A NO 20014022 A NO20014022 A NO 20014022A NO 20014022 L NO20014022 L NO 20014022L
Authority
NO
Norway
Prior art keywords
treatment
pharmaceutical composition
composition useful
sex hormones
nasal pharmaceutical
Prior art date
Application number
NO20014022A
Other languages
English (en)
Other versions
NO20014022D0 (no
Inventor
Yannis Tsouderos
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20014022D0 publication Critical patent/NO20014022D0/no
Publication of NO20014022L publication Critical patent/NO20014022L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20014022A 1999-03-31 2001-08-17 Anvendelse av kjönnshormoner for å oppnå en nasal farmasöytisk sammensetning som er nyttig i behandlingen av uönsketlivmorblödning NO20014022L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904022A FR2791572A1 (fr) 1999-03-31 1999-03-31 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
PCT/FR2000/000790 WO2000059447A2 (fr) 1999-03-31 2000-03-30 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables

Publications (2)

Publication Number Publication Date
NO20014022D0 NO20014022D0 (no) 2001-08-17
NO20014022L true NO20014022L (no) 2001-08-17

Family

ID=9543854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014022A NO20014022L (no) 1999-03-31 2001-08-17 Anvendelse av kjönnshormoner for å oppnå en nasal farmasöytisk sammensetning som er nyttig i behandlingen av uönsketlivmorblödning

Country Status (16)

Country Link
EP (1) EP1143978A2 (no)
JP (1) JP2002541076A (no)
KR (1) KR20010102464A (no)
CN (1) CN1346273A (no)
AU (1) AU3662300A (no)
BR (1) BR0008577A (no)
CA (1) CA2361885A1 (no)
EA (1) EA200100801A1 (no)
FR (1) FR2791572A1 (no)
HK (1) HK1044486A1 (no)
HU (1) HUP0200244A3 (no)
NO (1) NO20014022L (no)
NZ (1) NZ513672A (no)
PL (1) PL356767A1 (no)
WO (1) WO2000059447A2 (no)
ZA (1) ZA200106689B (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
CA2260253A1 (en) * 1996-07-23 1998-01-29 Clive L. Jennings-White Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety

Also Published As

Publication number Publication date
HUP0200244A3 (en) 2003-05-28
JP2002541076A (ja) 2002-12-03
WO2000059447A2 (fr) 2000-10-12
PL356767A1 (pl) 2004-07-12
EP1143978A2 (fr) 2001-10-17
KR20010102464A (ko) 2001-11-15
CN1346273A (zh) 2002-04-24
WO2000059447A3 (fr) 2001-04-26
NZ513672A (en) 2001-09-28
NO20014022D0 (no) 2001-08-17
ZA200106689B (en) 2002-11-14
CA2361885A1 (fr) 2000-10-12
HUP0200244A2 (hu) 2002-07-29
HK1044486A1 (zh) 2002-10-25
BR0008577A (pt) 2002-10-01
EA200100801A1 (ru) 2002-04-25
FR2791572A1 (fr) 2000-10-06
AU3662300A (en) 2000-10-23

Similar Documents

Publication Publication Date Title
EE200200535A (et) Konjugeeritud östrogeenide ja medroksüprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimisühik ja pakend
FR15C0069I2 (fr) Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques
ATE309206T1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
EE05378B1 (et) LahustuvaÁCTLA4ÁsulandmolekuliÁkasutamineÁravimkoostiseÁvalmistamiseks
HUP0201654A3 (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (ppar) alpha, their preparation and pharmaceutical composition containing the same
HUP0102899A3 (en) Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
NO20021898D0 (no) Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
NO20014022L (no) Anvendelse av kjönnshormoner for å oppnå en nasal farmasöytisk sammensetning som er nyttig i behandlingen av uönsketlivmorblödning
EE200900049A (et) Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
EE200200218A (et) 2-imidasolüül-asendatud karbinoolide kasutamine ravimi valmistamiseks isheemilistest seisunditest tingitud haiguste raviks või profülaktikaks
IL150122A0 (en) Remedies for external use for allergic skin diseases
AU6985900A (en) Use of n-acetyl-cysteine in the manufacture of topical pharmaceutical compositions for the treatment of allergic pathologies of the respiratory tract
EE200200348A (et) Ravimkoostis kasutamiseks valu ravis
IT1312060B1 (it) Uso dell'acido alfa lipoico nel trattamento antimetastatico.
ITMI20011284A0 (it) Composizione farmaceutica per il trattamento dell'iperfosfatemia
NO20015207L (no) Anvendelse av antiprogestagener i kombinert terapi
ATA171599A (de) Pharmazeutische zusammensetzung zur abdeckung des grundbedarfs an vitaminen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application